What is the average price target for MEDICINOVA INC (MNOV) stock?
10 analysts have analysed MNOV and the average price target is 9.18 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.44.
MEDICINOVA INC (MNOV) Forecast, Price Target & Analyst Ratings
NASDAQ:MNOV • US58468P2065
Current stock price
1.44 USD
+0.02 (+1.41%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICINOVA INC (MNOV).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.07
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$9.18
Upside
+ 537.50%
From current price of $1.44 to mean target of $9.18, Based on 10 analyst forecasts
Low
$6.06
Median
$9.69
High
$11.55
Price Target Revisions
1 Month
-10.00%
3 Months
28.57%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for MNOV. The average price target is 9.18 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 1.44.
The average price target has been revised upward by 28.57% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.00%
MNOV was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MNOV.
In the previous month the buy percentage consensus was at a similar level.
MNOV was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-23 | Maxim Group | Reiterate | Buy |
| 2026-03-16 | HC Wainwright & Co. | Initiate | Buy |
| 2026-01-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-12-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-31 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-24 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-16 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-04-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-02 | D. Boral Capital | Initiate | Buy |
| 2021-03-10 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.07
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -19.00%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A
Next Earnings Summary
MNOV is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1M | -100.00% | 409.7K | 127.5K -68.88% | 357K 180.00% | 43.544M 12,097.20% | 41.353M -5.03% | 164.66M 298.18% | 561.72M 241.14% | 967.03M 72.16% | 1.138B 17.68% | |
| EBITDA YoY % growth | -9.88M 32.38% | -12.654M -28.08% | -13.263M -4.81% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -9.9M 32.33% | -12.675M -28.03% | -13.283M -4.79% | -30.702M -131.14% | -34.68M -12.96% | -38.76M -11.76% | -6.066M 84.35% | 100.42M 1,755.47% | 465.4M 363.45% | 829.57M 78.25% | 982.86M 18.48% | |
| Operating Margin | -990.03% | N/A | -3,242.13% | -24,080.00% | -9,714.29% | -89.01% | -14.67% | 60.99% | 82.85% | 85.79% | 86.37% | |
| EPS YoY % growth | -0.18 42.14% | -0.23 -27.78% | -0.24 -4.35% | -0.33 -36.00% | -0.41 -25.00% | -0.45 -10.00% | -0.06 86.36% | 0.99 1,716.67% | 4.29 334.02% | 6.67 55.34% | 7.30 9.48% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 -19.00% | -0.07 -2.00% | -0.07 -13.34% | -0.07 -49.59% |
| Revenue Q2Q % growth | 44.197K -67.16% | 40.8K -66.92% | 81.6K -46.22% | |
| EBITDA Q2Q % growth | -3.264M | -3.672M -2.09% | -3.468M -3.05% | -4.896M -59.36% |
| EBIT Q2Q % growth | -3.867M 52.65% | -4.035M -11.87% | -4.372M -29.30% | -4.54M -46.81% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-23.20%
EPS Next 5 Year
43.68%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
557.78%
Revenue Next 5 Year
304.00%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MEDICINOVA INC / MNOV Forecast FAQ
When does MEDICINOVA INC (MNOV) report earnings?
MEDICINOVA INC (MNOV) will report earnings on 2026-05-11.
What are the consensus estimates for MNOV stock next earnings?
The consensus EPS estimate for the next earnings of MEDICINOVA INC (MNOV) is -0.07 USD and the consensus revenue estimate is 0 USD.
What is the number of analysts for MNOV stock?
The number of analysts covering MEDICINOVA INC (MNOV) is 10.